Background: More than half of the persons living with human immunodeficiency virus (HIV;
PLWH) in the US smoke cigarettes, and tobacco use is responsible for considerable …

Background: Tobacco use has emerged as the leading killer of persons living with HIV
(PLWH) in the United States. Little is known about the efficacy of tobacco treatment …

Introduction. HIV infected persons have high prevalence of smoking and tobacco‐
associated health risks. Few studies describe smoking cessation programs targeting this …

Introduction: Identifying successful smoking treatment interventions and methods of delivery
is critical given the smoking rates among HIV-positive populations and the medical …

This study examined the feasibility, acceptability, and outcomes of a culturally tailored
smoking cessation intervention for HIV-positive African American male smokers. Eligible …

Introduction: Tobacco use has emerged as a leading killer among persons living with HIV,
with effective approaches to tobacco treatment still unknown. HIV infection is nearly 3 times …

Objective: To assess the efficacy of behavioral interventions for smoking cessation among
HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane …

Introduction: People living with HIV/AIDS (PLWHA) are more likely to smoke cigarettes than
are individuals in the general population. The health implications of tobacco use are …

Most HIV-positive persons in the US smoke cigarettes. Despite substantial clinical advances
in HIV care in the era of highly active antiretroviral therapy (HAART), HIV-positive persons …

Cigarette smoking remains highly prevalent among persons living with human
immunodeficiency virus (HIV), estimated to be 40–75%, and is significantly higher than what …